Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
CO-PRESENTED BY
LIVE TV DownloadNews18 App
News18 English
»
1-min read

Alembic Pharmaceuticals Shares Jump 3.5% After Signing Pacts to Enter China

Alembic Pharma has signed a joint venture with SPH SINE Pharmaceutical Laboratories Co Ltd and Adia (Shanghai) Pharmaceuticals Co Ltd to promote and sell pharmaceutical products for the Chinese market.

Trending Desk

Updated:May 8, 2019, 3:35 PM IST
facebookTwittergoogleskypewhatsapp
Alembic Pharmaceuticals Shares Jump 3.5% After Signing Pacts to Enter China
Representative Image (Photo Credit: AFP)
Alembic Pharmaceuticals Ltd shares jumped as much as 3.5 per cent in early trade on Wednesday after the company said it has entered into a joint venture (JV) agreement with Chinese companies to foray into China, the world’s second largest drug market after the US.

Alembic Pharmaceuticals is also going to announce its March quarter earnings later in the day. According to Motilal Oswal, Alembic Pharmaceuticals is likely to report 2.6 per cent fall in its Q4 net profit to Rs 91.3 crore, while sales are expected to rise 10.8 per cent year-on-year to Rs 945.2 crore. The stock was trading at Rs 555, up 1 per cent, at 11:45 am on BSE after trimming its early gains.

Alembic Pharma has signed a joint venture with SPH SINE Pharmaceutical Laboratories Co Ltd and Adia (Shanghai) Pharmaceuticals Co Ltd to promote and sell pharmaceutical products for the Chinese market, as per the company’s filing on BSE.

SPH Sine will be the biggest stakeholder in the joint venture with 51 per cent stake, Alembic will hold 44 per cent share, while Adia will hold 5 per cent equity.

The JV will initially commercialize products manufactured by Alembic Pharmaceuticals in China and later plans to set up a manufacturing facility in the country. It plans to start operations in China by launching a portfolio of oral solids and is then expected to foray into other areas like injectables, ophthalmology, dermatology and oncology.

The registered capital of the new company will be 1 million Chinese yuan (approximately Rs 1 crore). The agreement was signed at Alembic Pharmaceuticals’s Vadodara headquarters.
Read full article
Next Story
Next Story

Also Watch

facebookTwittergoogleskypewhatsapp
 
 
Most Active
Company Price Change %Gain
Reliance 1,339.80 1.05
Indiabulls Hsg 807.75 -0.83
HDFC 2,114.50 -0.38
SBI 337.55 -2.07
Tata Motors 176.80 -7.02
Company Price Change %Gain
Reliance 1,339.75 1.08
SBI 337.55 -2.05
HDFC Bank 2,403.80 -1.20
Indiabulls Hsg 808.25 -0.35
Tata Motors 176.60 -7.05
Top Gainers
Company Price Change %Gain
Dr Reddys Labs 2,667.00 3.00
Bharti Infratel 276.10 2.43
Britannia 2,848.70 1.70
Reliance 1,339.80 1.05
Titan Company 1,244.40 1.04
Company Price Change %Gain
Reliance 1,339.75 1.08
Bajaj Finance 3,432.65 0.76
HUL 1,783.50 0.62
Top Losers
Company Price Change %Gain
Tata Motors 176.80 -7.02
BPCL 374.45 -4.43
Zee Entertain 347.70 -4.08
IndusInd Bank 1,447.75 -3.14
Adani Ports 387.60 -3.12
Company Price Change %Gain
Tata Motors 176.60 -7.05
Maruti Suzuki 6,857.80 -3.25
IndusInd Bank 1,447.55 -3.02
Bharti Airtel 330.80 -2.66
M&M 638.80 -2.36

Live TV

Countdown To Elections Results
  • 01 d
  • 12 h
  • 38 m
  • 09 s
To Assembly Elections 2018 Results